Clopidogrel for Proteinuria Reduction in Focal Segmental Glomerulosclerosis: Phase 2 Trial Design

Clopidogrel for Proteinuria Reduction in Focal Segmental Glomerulosclerosis: Phase 2 Trial Design

Saved in:

Bibliographic Details
Main Authors:	Lisa Daniel-Fischer, Marlies Antlanger, Daniel Cejka, Kathrin Eller, Philipp Gauckler, Balazs Odler, Michael Rudnicki, Marcus D. Säemann, Alice Schmidt, Gere Sunder-Plassmann, Martin Wiesholzer, Martin Windpessl, Emanuel Zitt, Franz Koenig, Larry A. Greenbaum, Andreas Kronbichler, Christoph Aufricht
Format:	Article
Language:	English
Published:	Elsevier 2024-02-01
Series:	Kidney International Reports
Subjects:	clopidogrel drug repurposing FSGS proteinuria
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468024923015693
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A polymeric dexamethasone prodrug attenuates focal segmental glomerulosclerosis (FSGS) in an Adriamycin-induced mouse model with minimal glucocorticoid side effects
by: Haochen Jiang, et al.
Published: (2025-03-01)

The predictive value of suPAR for glomerular segmental sclerosis lesions in renal pathology
by: Zurong Zhang, et al.
Published: (2025-12-01)

Defining subgroups of pediatric nephrotic patients with urine proteomics
by: Timothy D. Cummins, et al.
Published: (2025-07-01)

Comparison of clinical manifestations and prognosis between two pathological types of obesity-related glomerulopathy
by: LU Hai-tao, et al.
Published: (2019-01-01)

Soluble Urokinase Receptors in Focal Segmental Glomerulosclerosis: A Review on the Scientific Point of View
by: Andreas Kronbichler, et al.
Published: (2016-01-01)

WT1-Related Nephropathy in a Phenotypically Female Child: A Case of Clinical and Genetic Discordance
by: Mariana Costin, et al.
Published: (2025-05-01)

Quantifying Proteinuria in Hypertensive Disorders of Pregnancy
by: Sapna V. Amin, et al.
Published: (2014-01-01)

Prevalence of Proteinuria in Dogs With Immune‐Mediated Disease
by: James C. Barton, et al.
Published: (2025-07-01)

463 Identification of molecular and cellular events during recurrence of focal segmental glomerulosclerosis in human allografts
by: Haseeb Zubair, et al.
Published: (2025-04-01)

ANCA-Associated Glomerulonephritis: Diagnosis and Therapy Proceedings of the Henry Shavelle Lectureship
by: Vanja Ivković, et al.
Published: (2024-12-01)

WCN24-1899 RECURRENT FOCAL SEGMENTAL GLOMERULOSCLEROSIS IN KIDNEY TRANSPLANTATION
by: Adriana M. Lituma, et al.
Published: (2024-04-01)

Clinicopathological features of 60 cases of asymptomatic hematuria and/or proteinuria
by: GUO Chun-hua, et al.
Published: (2016-01-01)

Assessment of podocyte detachment as a pivotal step in the development of focal segmental glomerulosclerosis
by: Ikbal Ahmed Abdo Elkholy, et al.
Published: (2024-11-01)

Treatment of proteinuria with lercanidipine associated with reninangiotensin axis-blocking drugs
by: N. R. Robles, et al.
Published: (2011-06-01)

Retinal multimodal-imaging and functional tests in a mitochondrial disease with focal and segmental glomerulosclerosis
by: Xiao-Hong Liu, et al.
Published: (2025-09-01)

Current status of clinical studies of IgA nephropathy with minimal proteinuria
by: SHI Yu-zhen, et al.
Published: (2020-01-01)

Research advances of idiopathic membranous nephropathy with non-nephrotic range proteinuria
by: Sun Jing, et al.
Published: (2022-10-01)

Iptacopan Reduces Proteinuria and Stabilizes Kidney Function in C3 Glomerulopathy
by: Carla M. Nester, et al.
Published: (2025-02-01)

Changes and significance of blood/urine-related biomarkers in proteinuria induced kidney disease
by: Zhang Wen-juan, et al.
Published: (2021-01-01)

Rapamycin Ameliorates Proteinuria and Restores Nephrin and Podocin Expression in Experimental Membranous Nephropathy
by: Stavros Stratakis, et al.
Published: (2013-01-01)

WCN24-2707 Focal and Segmental Glomerulosclerosis and Chronic Inflammatory Demyelinating Polyradiculoneuropathy: a Case Report
by: Katia Olga Teresa Hernández Torres, et al.
Published: (2024-04-01)

WCN25-63 Refractory Nephrotic Syndrome in Focal and Segmental Glomerulosclerosis by PMM2 Genetic Variant
by: Jaime Arturo Dulce M, et al.
Published: (2025-02-01)

Comparative Analysis of Proteinuria and Longitudinal Outcomes in Immune Complex Membranoproliferative Glomerulonephritis and C3 Glomerulopathy
by: Fernando Caravaca-Fontán, et al.
Published: (2025-04-01)

Proteinuria is risk factor for abdominal aortic aneurysm: a nationwide population-based study
by: Kang Woong Jun, et al.
Published: (2025-05-01)

WCN25-4499 Collagenofibrotic glomerulopathy – a rare cause of Nephrotic range proteinuria
by: SRISHTI RATHI, et al.
Published: (2025-02-01)

Nephrotic Syndrome due to Focal Segmental Glomerulosclerosis Complicating Sjögren’s Syndrome: A Case Report and Literature Review
by: Shigekazu Kurihara, et al.
Published: (2019-01-01)

WCN24-1921 NEPHROTIC SYNDROME SECONDARY AND FOCAL SEGMENTAL GLOMERULOSCLEROSIS DUE TO PODOCYTE KANK-2 MUTATION
by: Sandra Liliana Borda Galindo, et al.
Published: (2024-04-01)

Prognostic Value of Urinary Biomarkers in Proteinuria Progression in IgA Nephropathy Patients Treated with Budesonide
by: Christodoulos Keskinis, et al.
Published: (2025-04-01)

On-treatment systolic blood pressure and preserved kidney function in hypertensive patients with proteinuria. The VALUE Trial
by: Eirik Olsen, et al.
Published: (2025-12-01)

Population risk predictors of major adverse kidney events attributed to focal segmental glomerulosclerosis from the CURE-CKD registry
by: Susanne B. Nicholas, et al.
Published: (2025-07-01)

Correlation of E1 Lesions and CD68 Count with Proteinuria and Clinical Outcome in IgA Nephropathy
by: Sistla Radha, et al.
Published: (2022-04-01)

Exploring the mechanism of proteinuria reduction by hydroxychloroquine in IgA nephropathy using network pharmacology and molecular mocking
by: Meiqi Lu, et al.
Published: (2025-07-01)

Focal segmental glomerulosclerosis (FSGS) in pregnancy: The case of a 27-year-old woman with nephrotic syndrome at 22 weeks of gestation
by: Lucy Wang, et al.
Published: (2024-11-01)

Focal Segmental Glomerulosclerosis and Scheduled Pretransplant Plasmapheresis: A Timely Diagnosis of Nail-Patella Syndrome Avoided More Futile Immunosuppression
by: H. Trimarchi
Published: (2020-01-01)

WCN25-2195 CLINICAL COURSE AND OUTCOME OF ADULT PATIENTS WITH PRIMARY FOCAL SEGMENTAL GLOMERULOSCLEROSIS WITH KIDNEY FUNCTION LOSS ON PRESENTATION
by: Nazarul Hassan Jafry, et al.
Published: (2025-02-01)

Proteinuria reduction by and safety of finerenone in Chinese patients with CKD without diabetes: a real-world retrospective study
by: Guangting Cong, et al.
Published: (2025-08-01)

WCN25-927 PREVALENCE OF PROTEINURIA, HYPERTENSION, AND DIABETES IN AN INDIGENOUS POPULATION OF THE BIODIVERSE JUNGLE OF THE COLOMBIAN PACIFIC COAST
by: ROBERTO RAMIREZ MARMOLEJO, et al.
Published: (2025-02-01)

WCN25-2015 EFFICACY OF RITUXIMAB IN MINIMAL CHANGE DISEASE AND FOCAL SEGMENTAL GLOMERULOSCLEROSIS : A SINGLE CENTRE EXPERIENCE FROM INDIA
by: Harshkumar Patel, et al.
Published: (2025-02-01)

Primary focal segmental glomerulosclerosis in second trimester pregnancy presenting as rapidly progressive renal failure: diagnostic and therapeutic challenges: a case report
by: Adane Petros, et al.
Published: (2025-07-01)

Potential Association between Breakfast Skipping and Concomitant Late-Night-Dinner Eating with Metabolic Syndrome and Proteinuria in the Japanese Population
by: Ayano Kutsuma, et al.
Published: (2014-01-01)